Biomarker Assessment Results Intended for Correlation with Cancer Clinical OutcomesStatus: open
Caris Registry "A Registry of Caris Life Sciences Molecular Intelligence™ Service (Biomarker Assessment Results) Intended for Correlation with Cancer Clinical Outcomes.
Treatment for Solid Tumors
This data collection Registry is a multi-center, observational outcomes Database designed to collect data on the demographics, presentation, diagnosis, treatment, resource use, quality of life and outcomes of subjects utilizing Caris Molecular Intelligence™ Services for treatment of solid tumor cancer.
Inclusion Criteria: Age greater than or equal to 19 years; Solid Tumor analyzed by Caris Molecular Intelligence™ Service Profile(s) and/or Next-Generation Sequencing Exclusion Criteria: Individual test orders, defined as single biomarker assessment; prisoners-patients
SponsorsThis trial is sponsored by Caris.
Interested in Clinical Trial?
Providers Associated With This Trial
- Michael A. Finan, M.D., F.A.C.S., F.A.C.O.GGynecologic OncologistProfessor of Interdisciplinary Clinical Oncology